MRSA therapeutics market to reach $1.8bn across 7MM in 2034

The MRSA therapeutics market is forecast to grow from $1.3bn in 2024 to $1.8bn in 2034 at a compound annual growth rate (CAGR) of 3.4%. The MRSA therapeutics market is forecast to grow from $1.3bn in 2024 to $1.8bn in 2034 at a compound annual growth rate (CAGR) of 3.4%. Hospitalised incident cases of MRSA in the 7MM are projected to increase at an annual growth rate of 1.10% between 2024 and 2034. Credit: Ezume Images via Shutterstock.com. Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research,…

Source: Clinical Trials Arena